Nanotechnology for Alzheimer Disease.

导出原文传递

翻译打印收藏纠错

第一作者： Jerzy,Leszek

第一单位： Department of Psychiatry, Wroclaw Medical University, Wroclaw. Poland.

作者： Jerzy,Leszek ^[1] ; Ghulam,Md Ashraf ^[2] ; Wai Hei,Tse ^[3] ; Jin,Zhang ^[3] ; Kazimierz,Gasiorowski ^[4] ; Marco Fidel,Avila-Rodriguez ^[5] ; Vadim V,Tarasov ^[6] ; George E,Barreto ^[5] ; Sergey G,Klochkov ^[7] ; Sergey O,Bachurin ^[7] ; Gjumrakch,Aliev ^[8]

作者单位： Department of Psychiatry, Wroclaw Medical University, Wroclaw. Poland. ^[1] King Fahd Medical Research Center, King Abdulaziz University, Jeddah. Saudi Arabia. ^[2] University of Western Ontario, Department of Medical Biophysics, Ontario. Canada. ^[3] Department of Basic Medical Sciences, Wroclaw Medical University, Wroclaw. Poland. ^[4] Departamento de Nutricion y Bioquimica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogota D.C.. Colombia. ^[5] Institute of Pharmacy and Translational Medicine, Sechenov First Moscow State Medical University, 119991, Moscow. Russian Federation. ^[6] Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow Region, 142432. Russian Federation. ^[7] "GALLY" International Biomedical Research Consulting LLC, San Antonio, TX 78229. United States. ^[8]

关键词 Alzheimer's disease dementia drug delivery nanoparticles neurofibrillary tangles neuroprotection

主题词阿尔茨海默病(Alzheimer Disease);动物(Animals);药物释放系统(Drug Delivery Systems);人类(Humans);纳米粒子(Nanoparticles);纳米技术(Nanotechnology)

DOI 10.2174/1567205014666170203125008

PMID 28164767

发布时间 2018-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交